Quantum X Labs Inc.

https://view-bix.com

Quantum X Labs Inc., formerly known as Viewbix Inc., is an Israel-based advanced technologies company that has strategically pivoted its core business to focus on quantum computing and related technologies, while continuing to operate its digital advertising platforms. Headquartered in Tel Aviv, Israel, the company's mission is to develop and commercialize innovative quantum solutions across various sectors.

Initially established as a digital advertising platform, the company's offerings now span a broad range of quantum technologies, including quantum algorithms for transportation, drug discovery, biomedicine, and security, as well as quantum-based navigation systems, next-generation atomic clocks, and advanced quantum error correction technologies. Through its subsidiaries, such as Gix Media Ltd. and Metagramm Software Ltd., it also maintains its legacy operations in ad-search and digital content, providing technological software solutions to automate, optimize, and monetize online campaigns.

Effective April 30, 2026, Viewbix Inc. officially rebranded to Quantum X Labs Inc. and began trading on the Nasdaq Capital Market under the new ticker symbol QXL, following its acquisition of Quantum X Labs Ltd. in March 2026. This rebranding signifies a significant strategic shift from its traditional ad-tech roots towards becoming a developer and owner of quantum computing technologies. Amihay Hadad serves as the Chief Executive Officer.

Latest updates

Viewbix Rebrands as Quantum X Labs, Signals Pivot to Quantum Tech

Event summary

  • Viewbix Inc. (VBIX) is rebranding to Quantum X Labs Inc. (QXL), effective April 30, 2026.
  • The rebranding accompanies the acquisition of a quantum technology subsidiary, Quantum X Labs Ltd., in March 2026.
  • Quantum X Labs Ltd. holds a pending patent for AI-Quantum Error Correction and manages a portfolio of quantum technology subsidiaries.
  • The company will continue its digital advertising and AI-driven computing solutions business through existing subsidiaries.
  • The ticker symbol will change from VBIX to QXL.

The big picture

The rebranding signals a significant strategic pivot for Viewbix, moving away from its digital advertising roots and aggressively pursuing the high-growth, but capital-intensive, quantum computing market. This move reflects the increasing global investment in quantum technologies, driven by both commercial and national security interests. The acquisition of Quantum X Labs Ltd. suggests an attempt to shortcut the lengthy R&D process, but the success of this strategy hinges on the integration of the subsidiary and the commercialization of its intellectual property.

What we're watching

Financial Impact
The market's reaction to the rebranding and shift in focus will be critical, as investors assess the viability of Quantum X Labs' quantum technology portfolio versus its legacy digital advertising business.
Patent Validation
The value of the AI-Quantum Error Correction patent and the broader intellectual property portfolio will need to be validated through successful development and potential licensing deals.
Subsidiary Performance
The financial performance and technological progress of the various subsidiaries (Quantum Gyro, Quantum Atom Accuracy, etc.) will be key indicators of Quantum X Labs' overall success in the quantum technology space.

Viewbix Subsidiary Advances Quantum Nuclear Simulation, Targets Industry Integration

Event summary

  • Nuclear Quantum, a subsidiary of Viewbix’s Quantum X Labs, has achieved a milestone in its development of quantum-based simulation algorithms.
  • The milestone marks a shift from core algorithm development to targeted industry engagement and collaboration with established simulation companies.
  • Nuclear Quantum aims to integrate its quantum algorithms into existing modeling platforms to accelerate adoption and minimize disruption.
  • The global market for Nuclear Power Simulation Software is projected to reach $321 million by 2031, growing at a CAGR of 5.2%.

The big picture

Viewbix’s investment in Quantum X Labs and Nuclear Quantum represents a bet on the future of nuclear energy and engineering simulation, both of which are undergoing a digital transformation. The company is attempting to capitalize on the growing demand for faster, more accurate simulations, a market currently valued at $226 million and projected to reach $321 million by 2031. This move positions Viewbix to potentially disrupt a traditionally slow-moving industry, but faces the inherent risks of early-stage quantum technology adoption.

What we're watching

Adoption Rate
The success of Nuclear Quantum hinges on the willingness of established simulation companies to integrate its algorithms, and the pace of that adoption will dictate near-term revenue potential.
Competitive Landscape
While quantum simulation holds promise, Nuclear Quantum faces competition from traditional simulation methods and potentially other quantum-based solutions, requiring a differentiated value proposition.
Technical Feasibility
The ‘precision vs. time’ bottleneck in nuclear simulations is a significant challenge; whether Nuclear Quantum’s algorithms can truly deliver on their performance promises remains to be seen.

Viewbix Subsidiary Patents NMR Gyroscope Tech, Eyes GPS Independence

Event summary

  • Viewbix’s Quantum X Labs filed a provisional patent application for a nuclear magnetic resonance (NMR) gyroscope hardware architecture.
  • Quantum X Labs entered into a license agreement with Quantum Gyro Ltd., a subsidiary, to develop and commercialize the technology.
  • Taurus Gold Corp. completed a $200,000 equity investment in Viewbix as a condition of the license agreement.
  • The technology aims to reduce or replace reliance on GPS for navigation and stabilization in various sectors.

The big picture

The development of GPS-independent navigation systems is increasingly important due to geopolitical instability and concerns about reliance on satellite infrastructure. Viewbix’s NMR gyroscope technology represents a potential disruptive innovation in a market dominated by established players, but faces significant technical and commercialization hurdles. The license agreement with Quantum Gyro and the Taurus Gold investment suggest a deliberate strategy to leverage a minority-owned entity for specialized development and market access.

What we're watching

Patent Outcome
The USPTO’s decision on the patent application will be critical, as it dictates Quantum X Labs’ ability to protect and commercialize the technology, and will influence Quantum Gyro’s development roadmap.
Commercialization
The success of Quantum Gyro’s efforts to develop a low-bias drift NMR gyroscope will determine if the technology can genuinely compete with existing high-end navigation systems and achieve market adoption.
Strategic Alignment
Viewbix’s diverse business segments (quantum tech, advertising, AI) raise questions about how effectively it will allocate resources to support Quantum X Labs and Quantum Gyro’s commercialization efforts, given competing priorities.

Viewbix Bolsters Quantum Portfolio with Quantum X Labs Acquisition

Event summary

  • Viewbix Inc. completed the acquisition of Quantum X Labs Ltd. on March 4, 2026.
  • The deal includes Quantum X Labs’ intellectual property, notably a patent for AI-Quantum Error Correction.
  • Viewbix issued approximately 40% of its capital stock (including 800,000 shares) and pre-funded warrants for the acquisition, with potential for up to 12.7 million additional shares/warrants.
  • A private placement of approximately $1.4 million in Viewbix common stock and warrants was also completed, with proceeds earmarked for general corporate purposes.

The big picture

Viewbix’s acquisition of Quantum X Labs signals a significant bet on the burgeoning quantum technology sector, which is attracting increasing investment despite its nascent stage. The substantial equity issuance and private placement highlight the capital intensity of quantum development and the perceived strategic importance of securing advanced IP. This move positions Viewbix to capitalize on potential breakthroughs in areas like navigation, timing, and computation, but also introduces considerable execution and market risk.

What we're watching

Milestone Risk
The potential issuance of up to 12.7 million additional shares/warrants hinges on achieving post-closing milestones, introducing significant dilution risk if these targets are not met.
Integration Costs
Integrating Quantum X Labs, a multi-disciplinary hub, will likely incur substantial integration costs and may present operational challenges that could impact Viewbix’s profitability.
Market Validation
The commercial viability of Quantum X Labs’ technologies, particularly in areas like quantum-based navigation and drug discovery, remains unproven and will determine the long-term value of the acquisition.

Viewbix Acquires Quantum X Labs, Issues Substantial Equity

Event summary

  • Viewbix Inc. (VBIX) completed the acquisition of Quantum X Labs Ltd. on March 4, 2026.
  • The acquisition includes Quantum X Labs’ intellectual property, notably a patent for AI-Quantum Error Correction.
  • Viewbix issued approximately 40% of its capital stock (including 800,000 shares in a private placement) and pre-funded warrants for the acquisition, with potential for additional shares/warrants based on milestones.
  • A private placement of $1.4 million in Viewbix common stock and warrants was also completed, with proceeds earmarked for general corporate purposes.
  • The private placement occurred at $1.75 per share and included warrants with a 5-year term exercisable at $2.625 per share.

The big picture

Viewbix’s acquisition of Quantum X Labs represents a significant bet on the nascent quantum technology sector, a field attracting increasing investment despite its long-term development timeline. The deal, financed through a large equity issuance and private placement, signals a strategic shift for Viewbix, moving beyond its core digital advertising business into a high-risk, high-reward technology space. The significant equity dilution raises questions about the company’s ability to deliver sufficient returns to justify the investment and maintain investor confidence.

What we're watching

Milestone Achievement
The potential issuance of additional shares/warrants hinges on achieving post-closing milestones; failure to meet these could impact Viewbix’s equity structure and investor sentiment.
Integration Risk
Integrating Quantum X Labs’ diverse portfolio companies and technologies into Viewbix’s existing digital advertising and software businesses presents significant operational and cultural integration risks.
Capital Structure
The substantial equity issuance and warrants dilute existing shareholders and could place downward pressure on the stock price if the acquisition doesn't deliver expected returns.

Viewbix Subsidiary Advances Quantum Decoder Cloud Implementation

Event summary

  • Quantum Transportation, a subsidiary of Quantum X Labs, has completed a key cloud implementation milestone for its transformer-based quantum decoder.
  • The implementation involved deploying the decoder on Amazon Web Services (AWS) to enable processing of complex quantum data at scale.
  • Viewbix is in the process of acquiring up to 100% of Quantum X Labs, a deal expected to close within 90 days of December 15, 2025.
  • The milestone paves the way for testing the decoder on physical quantum hardware across various architectures.

The big picture

Viewbix’s acquisition of Quantum X Labs represents a strategic bet on the burgeoning quantum computing market, which is still in its nascent stages. The company's current business is centered on digital advertising, and this move signals a diversification effort into a high-growth, but capital-intensive, sector. The successful integration of Quantum Transportation’s technology will be crucial for Viewbix to realize the potential value of this acquisition.

What we're watching

Acquisition Risk
The acquisition of Quantum X Labs carries integration risk, as Viewbix absorbs a new subsidiary with a distinct technology focus. The closing timeline, contingent on customary conditions, remains a key factor to monitor.
Hardware Integration
The success of Quantum Transportation’s decoder will hinge on its ability to effectively integrate with diverse quantum hardware architectures, which could reveal unforeseen technical challenges.
Commercialization
While the cloud implementation is a significant technical step, the path to commercialization for Quantum Transportation’s decoder remains uncertain, and depends on identifying viable applications and partnerships.

Viewbix to Acquire Quantum X Labs, Bolstering Navigation Tech Portfolio

Event summary

  • Viewbix Inc. (VBIX) is acquiring Quantum X Labs Ltd., including its subsidiary Quantum Gyro, for up to 100% in a deal expected to close within 90 days.
  • Quantum Gyro has reportedly achieved significant performance improvements in gyroscope technology, potentially enabling unjammable, satellite-free navigation.
  • Viewbix received stockholder approval for the acquisition on January 5, 2026, and filed a definitive information statement on January 15, 2026.
  • The global quantum compass navigation market is projected to reach $3.64 billion by 2033, with a CAGR of 29.4%.

The big picture

Viewbix’s acquisition of Quantum X Labs represents a strategic pivot away from its core digital advertising business towards high-growth, high-margin advanced technologies. The move positions Viewbix to capitalize on the increasing demand for secure, autonomous navigation systems, particularly in sectors like defense and aerospace, which are increasingly reliant on GPS-denied operations. The acquisition also brings valuable quantum error correction IP, potentially benefiting other areas of Viewbix’s technology portfolio.

What we're watching

Integration Risk
The success of the acquisition hinges on Viewbix’s ability to effectively integrate Quantum X Labs’ technology and personnel, particularly given the differing operational focuses of Viewbix’s existing digital advertising businesses.
Commercialization
The timeline for Quantum Gyro’s technology to transition from laboratory experiments to commercial deployment remains uncertain, and delays could impact Viewbix’s return on investment.
Competitive Landscape
While Quantum Gyro’s advancements are significant, the emergence of competing quantum navigation solutions could erode Viewbix’s competitive advantage and market share.

Viewbix Subsidiary Advances Quantum Clock Tech, Acquisition Timeline Nears

Event summary

  • Quantum Accuracy, a subsidiary of Quantum X Labs, has demonstrated significant progress in developing a novel atomic clock using a light-modulation scheme.
  • Viewbix is in the process of acquiring Quantum X Labs for up to 100%, a deal expected to close within 90 days of December 15, 2025.
  • Shareholder approval for the acquisition was secured on January 5, 2026, and a definitive information statement was filed with the SEC on January 15, 2026.
  • The new atomic clock technology aims for ultra-stable, compact timing references, targeting aerospace, defense, and navigation applications.

The big picture

Viewbix’s move into quantum technologies through the acquisition of Quantum X Labs signals a strategic pivot away from its core digital advertising business. The development of this novel atomic clock, if successful, could position Viewbix in a high-value, niche market with significant defense and aerospace implications. However, the acquisition carries integration risk and the technology’s commercial viability remains unproven.

What we're watching

Acquisition Risk
The acquisition's closing remains contingent on regulatory approvals and customary closing conditions, introducing potential delays or complications that could impact Viewbix’s strategic direction.
Commercialization
The ability of Quantum Accuracy to translate laboratory results into commercially viable products for aerospace, defense, and navigation will be crucial for justifying the acquisition cost and realizing the technology's potential.
Patent Landscape
The success of Viewbix’s patent application for the light-modulation technique will determine the extent of its competitive advantage and ability to monetize the technology in the long term.

Viewbix Advances Quantum Error Correction, Acquisition Timeline Nears

Event summary

  • Viewbix subsidiary Quantum Transportation completed Milestone 1 of its Transformer-Based Quantum Decoder program, a key step for quantum error correction.
  • Milestone 1 involved a patent feasibility assessment, QEC model research, and finalizing a transformer architecture.
  • Completion of Milestone 1 secured rights related to a pending patent for a machine-learning-powered QEC decoder from Ramot at Tel Aviv University.
  • Viewbix is in the process of acquiring up to 100% of Quantum X Labs, expected to close within 90 days of December 15, 2025, with stockholder approval already secured.
  • Quantum Transportation is now moving to Milestone 2: System Proof of Concept, involving expanded simulations and discussions with potential partners.

The big picture

Viewbix's push into quantum computing, through the acquisition of Quantum X Labs, represents a significant bet on a technology poised to disrupt multiple industries. Quantum Error Correction remains a critical bottleneck for practical quantum computers, and Viewbix's approach leveraging transformer-based AI could offer a competitive advantage. The successful integration of Quantum Transportation's technology and intellectual property will be key to realizing the potential value of the acquisition.

What we're watching

Acquisition Risk
The acquisition of Quantum X Labs remains contingent on final due diligence and regulatory approvals, introducing potential delays or deal restructuring.
Technical Validation
The success of Milestone 2, the System Proof of Concept, will be crucial in validating the decoder's performance and scalability beyond simulations.
Competitive Landscape
How Viewbix’s QEC decoder technology will compare to competing approaches from other quantum computing players will determine its long-term market viability.

Viewbix Secures Key Quantum Decoder IP, Acquisition of Quantum X Labs Looms

Event summary

  • Quantum Transportation, a Viewbix subsidiary, completed Milestone 1 in its transformer-based quantum decoder program.
  • Completion of Milestone 1 secured a key intellectual property license from Ramot at Tel Aviv University, covering a machine learning-based quantum error correction decoder.
  • Viewbix plans to acquire up to 100% of Quantum X Labs, with a deal expected to close within 90 days of December 15, 2025.
  • Milestone 1 validated a transformer-based decoding architecture and demonstrated potential performance improvements over traditional methods.

The big picture

Viewbix’s strategic pivot towards quantum technologies, underscored by the Quantum X Labs acquisition, signals a bet on the long-term potential of fault-tolerant quantum computing. Securing the IP license from Tel Aviv University is a crucial step, but the acquisition’s success hinges on integrating Quantum X Labs’ technology and talent while navigating the inherent risks of early-stage quantum development. The move positions Viewbix to capitalize on the growing demand for advanced computing solutions across sectors like transportation and security, but the technology remains years from widespread commercial viability.

What we're watching

Acquisition Integration
The successful integration of Quantum X Labs’ patent portfolio and team into Viewbix will be critical for realizing the anticipated synergies and avoiding operational disruption.
Decoder Validation
The progress of Milestone 2, the System Proof of Concept, will determine whether the transformer-based decoder can deliver on its promise of improved efficiency and scalability in real-world quantum computing applications.
Competitive Landscape
The pace at which Viewbix can commercialize its quantum decoder technology will be influenced by the competitive efforts of other firms developing quantum error correction solutions.

Viewbix to Acquire Quantum X Labs, Bolsters AI Patent Portfolio

Event summary

  • Viewbix Inc. (VBIX) is acquiring Quantum X Labs, encompassing its patent portfolio, for an undisclosed sum.
  • The acquisition is expected to close within 90 days, following shareholder approval received January 5, 2026.
  • Quantum X Labs holds intellectual property related to quantum error correction codes (QECC), crucial for advancing practical quantum computing.
  • Mobileye recently acquired Mentee Robotics, previously led by Prof. Lior Wolf, highlighting a trend of consolidation in robotics and AI.
  • Viewbix previously signed a definitive agreement to acquire up to 100% of Quantum X Labs on December 15, 2025.

The big picture

Viewbix’s acquisition of Quantum X Labs signals a strategic pivot towards advanced technologies, specifically quantum computing, despite its current core business in digital advertising. This move reflects a broader trend of established tech companies seeking to secure a foothold in nascent, high-potential fields like quantum computing, often through IP acquisition. The acquisition of Quantum X Labs, coupled with Mobileye’s acquisition of Mentee Robotics, underscores the increasing importance of error correction and system-level problem-solving in both robotics and quantum computing.

What we're watching

Integration Risk
The success of the acquisition hinges on Viewbix’s ability to effectively integrate Quantum X Labs’ IP and talent, particularly given Viewbix’s existing focus on digital advertising and grammatical error correction software.
Quantum Adoption
The pace at which Viewbix can commercialize the QECC technology will determine the acquisition’s long-term value, as practical quantum computing remains years from widespread adoption.
Competitive Landscape
How Mobileye leverages the acquired Mentee Robotics technology will influence the competitive dynamics in the autonomous vehicle space and potentially impact Viewbix’s quantum computing ambitions.

Viewbix Secures Shareholder Approval for Quantum X Labs Acquisition

Event summary

  • Viewbix Inc. received stockholder approval via written consent for its acquisition of Quantum X Labs.
  • The acquisition will involve Viewbix acquiring 85% to 100% of Quantum X Labs’ share capital.
  • Viewbix will issue approximately 40% of its capital stock (including 800,000 shares in a private placement) and pre-funded warrants, with potential for up to 12.7 million additional shares/warrants based on milestones.
  • The transaction remains subject to closing conditions, including final due diligence and regulatory approvals, with closure expected in the coming weeks.

The big picture

Viewbix's acquisition of Quantum X Labs represents a significant, albeit unusual, strategic pivot for the digital advertising company. The move signals an attempt to diversify beyond its core business and enter the high-growth, but capital-intensive, quantum technology sector. The deal, involving a substantial equity stake (up to 40% of Viewbix’s capital stock), suggests a long-term commitment to quantum innovation, but also carries considerable execution and integration risk.

What we're watching

Integration Risk
Successfully integrating Quantum X Labs’ diverse portfolio companies and intellectual property will be crucial, and potential conflicts between Viewbix’s digital advertising focus and Quantum’s advanced technology development could hinder progress.
Milestone Dependency
The potential issuance of significant additional shares/warrants hinges on the achievement of post-closing milestones, which introduces uncertainty regarding Viewbix’s future capital structure and potential dilution.
Regulatory Scrutiny
Given the strategic importance of quantum technologies and potential national security implications, the acquisition may face heightened regulatory scrutiny, potentially delaying or complicating the closing process.

Viewbix to Acquire Quantum X Labs, Expanding into Quantum Technology

Event summary

  • Viewbix Inc. (VBIX) is pursuing an acquisition of 85%-100% of Quantum X Labs Ltd., Israel’s multi-disciplinary quantum technology laboratory.
  • The deal, announced in December 2025, is valued at an undisclosed amount and expected to close within 90 days (around March 2026).
  • Quantum X Labs operates five portfolio companies focused on quantum navigation, error correction, algorithmic platforms, atomic clocks, and security.
  • The acquisition includes Quantum X Labs’ patent portfolio, including prior IP in quantum error correction, and leverages talent from leading Israeli academic institutions.

The big picture

Viewbix’s move signals a growing recognition of quantum technology’s potential beyond academic research, with the acquisition positioning the company to capitalize on emerging markets like secure communications and personalized medicine. The deal highlights Israel’s emergence as a key hub for quantum innovation, attracting investment from international players. While the acquisition price remains undisclosed, the strategic rationale suggests Viewbix is willing to invest significantly to gain a foothold in this nascent but rapidly evolving sector.

What we're watching

Regulatory Scrutiny
Given the strategic importance of quantum technology and the involvement of Israeli entities, regulatory approvals could face increased scrutiny, potentially delaying the acquisition timeline.
Integration Risk
Successfully integrating Quantum X Labs’ diverse portfolio companies and multidisciplinary team into Viewbix’s existing digital advertising business presents a significant operational challenge.
Commercialization Pace
The speed at which Quantum X Labs’ technologies can be commercialized and generate revenue will be critical to justifying Viewbix’s investment and realizing the anticipated market opportunities.

Viewbix Bets on Quantum Computing for Clinical Trial Revolution

Event summary

  • Viewbix Inc. announced a provisional patent filing by its Quantum X Labs subsidiary for a technology enhancing Markov Chain Monte Carlo (MCMC) methods using quantum computing.
  • The technology aims to improve clinical trial data analysis by creating 'quantum-resolved biological maps' and identifying patient clusters and treatment responses.
  • Viewbix has a definitive agreement to acquire up to 100% of Quantum X Labs, with a deal value implied by the acquisition of its patent portfolio.
  • The acquisition is expected to close within 90 days, pending due diligence, regulatory approvals, and stockholder approval.
  • Quantum X Labs also holds prior IP in quantum error correction, which is included in the acquisition.

The big picture

Viewbix's move signals a growing interest in applying quantum computing to complex biological datasets, a field with the potential to significantly accelerate drug discovery and personalized medicine. The acquisition of Quantum X Labs represents a strategic bet on this nascent technology, but the success hinges on the technology's practical application and market acceptance. The deal, if completed, could position Viewbix to capitalize on the increasing demand for more efficient and precise clinical trial methodologies.

What we're watching

Acquisition Risk
The acquisition's closing hinges on several conditions, including regulatory approvals and stockholder votes, creating potential for delays or termination.
Technology Validation
The efficacy of the quantum-enhanced MCMC methodology in real-world clinical trials remains to be demonstrated, and its impact on trial timelines and costs is speculative.
Market Adoption
Widespread adoption of quantum-resolved biological maps within the pharmaceutical industry will depend on convincing established players of the technology's value and integrating it into existing workflows.
CID: 250